<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Exp Rheumatol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Exp Rheumatol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Clinical and experimental rheumatology</journal-title></journal-title-group><issn pub-type="ppub">0392-856X</issn><issn pub-type="epub">1593-098X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10523932</article-id><article-id pub-id-type="pmcid-ver">PMC10523932.319</article-id><article-id pub-id-type="pmcaid">10523932</article-id><article-id pub-id-type="pmcaiid">10523932</article-id><article-id pub-id-type="manuscript-id">NIHMS1896751</article-id><article-id pub-id-type="pmid">37083174</article-id><article-id pub-id-type="doi">10.55563/clinexprheumatol/3bu1sf</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1896751</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1896751</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Opioid Use in Youth with Inflammatory Bowel Disease Related Arthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Dagci</surname><given-names initials="AOB">Atiye O Bilgic</given-names></name><degrees>MD</degrees><aff id="A1">Division of Rheumatology, Children&#8217;s Hospital of Philadelphia, Philadelphia, PA, Division of Pediatric Rheumatology, University of Michigan, Ann Arbor, MI</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="JC">Joyce C</given-names></name><degrees>MD MSCE</degrees><aff id="A2">Division of Immunology, Boston Children&#8217;s Hospital and Harvard Medical School, Boston MA Division of Rheumatology, Department of Pediatrics, Center for Pediatric Clinical Effectiveness, University of Pennsylvania Perelman School of Medicine and Children&#8217;s Hospital of Philadelphia, Philadelphia, PA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xiao</surname><given-names initials="R">Rui</given-names></name><degrees>PhD</degrees><aff id="A3">Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grossman</surname><given-names initials="AB">Andrew B.</given-names></name><degrees>MD</degrees><aff id="A4">Division of Gastroenterology, Hepatology, and Nutrition, Children&#8217;s Hospital of Philadelphia, Philadelphia, PA</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weiss</surname><given-names initials="PF">Pamela F</given-names></name><degrees>MD MSCE</degrees><aff id="A5">Division of Rheumatology, Department of Pediatrics, Center for Pediatric Clinical Effectiveness, University of Pennsylvania Perelman School of Medicine and Children&#8217;s Hospital of Philadelphia, Philadelphia, PA</aff></contrib></contrib-group><author-notes><corresp id="CR1">Corresponding Author: Atiye O. Bilgic Dagci, Address: CHOP Roberts Center for Pediatric Research 734 Schuylkill Ave, Philadelphia, PA 19146, Tel: 215 590 2547; <email>olcaybilgicdagci@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>4</month><year>2023</year></pub-date><volume>41</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">446078</issue-id><fpage>1553</fpage><lpage>1560</lpage><pub-history><event event-type="nihms-submitted"><date><day>14</day><month>05</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-07-01 00:25:30.177"><day>01</day><month>07</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1896751.pdf"/><abstract id="ABS1"><sec id="S1"><title>OBJECTIVE</title><p id="P1">Concomitant arthritis may increase risk of chronic opioid use in youth with IBD. We aimed to assess trends and clinical features associated with opioid use in children with IBD-related arthritis.</p></sec><sec id="S2"><title>METHODS</title><p id="P2">Youth less than 18 years of age with IBD-related arthritis, at least 1 year of continuous enrollment, and at least 1 pharmacy claim in the Truven Health MarketScan Claims and Encounter Database were included. Subjects were identified using previously validated algorithms consisting of ICD codes, pharmacy claims and procedure codes. The primary outcome was chronic opioid exposure. Temporal trends in opioid exposure were tested using the Cuzick-Wilcoxon test. The association of chronic opioid use and baseline covariates in the IBD and IBD-arthritis cohorts were examined using multivariable logistic regression models.</p></sec><sec id="S3"><title>RESULTS</title><p id="P3">14,943 youth with IBD, 480 of whom had arthritis, were included. Chronic opioid use was non-trivial in youth with IBD-related arthritis, higher than that of total IBD cohort (12.3% vs 5%) and remained stable over the years of study. Using multivariable regression, joint pain and arthritis were significantly associated with chronic opioid exposure in youth with IBD. Among IBD-related arthritis patients older age, public insurance, gastrointestinal surgery, hospitalization and psychiatric comorbidities were significantly associated with chronic opioid use.</p></sec><sec id="S4"><title>CONCLUSION</title><p id="P4">Chronic opioid use in youth with IBD-related arthritis was higher than that of total IBD cohort but stable over the years of study. Future study is needed to explore ways to optimize non-narcotic pain management strategies and ensuring appropriate use of opioids when necessary.</p></sec></abstract><kwd-group><kwd>opioid</kwd><kwd>analgesic</kwd><kwd>inflammatory bowel disease</kwd><kwd>children</kwd><kwd>arthritis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>